Baiji Shenzhou (06160.HK) plans to issue and distribute 133 million new shares to BGNC2 in 2016.

Zhijun Financial APP News, BGI Genomics (06160.HK) announced that on December 7, 2018, the Company's shareholders approved the second revised and restated 2016 stock option and incentive plan. In 2020, 2022, and 2024, the Company's shareholders have approved multiple revisions to the 2016 plan to increase the number of authorized shares to be issued under the 2016 plan, providing continued incentive opportunities.